These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 35062948)

  • 1. LRG1: an emerging player in disease pathogenesis.
    Camilli C; Hoeh AE; De Rossi G; Moss SE; Greenwood J
    J Biomed Sci; 2022 Jan; 29(1):6. PubMed ID: 35062948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency.
    O'Connor MN; Kallenberg DM; Camilli C; Pilotti C; Dritsoula A; Jackstadt R; Bowers CE; Watson HA; Alatsatianos M; Ohme J; Dowsett L; George J; Blackburn JWD; Wang X; Singhal M; Augustin HG; Ager A; Sansom OJ; Moss SE; Greenwood J
    Med; 2021 Nov; 2(11):1231-1252.e10. PubMed ID: 35590198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disruptive role of LRG1 on the vasculature and perivascular microenvironment.
    Dritsoula A; Camilli C; Moss SE; Greenwood J
    Front Cardiovasc Med; 2024; 11():1386177. PubMed ID: 38745756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multifunctional Role of Leucine-Rich α-2-Glycoprotein 1 in Cutaneous Wound Healing Under Normal and Diabetic Conditions.
    Liu C; Teo MHY; Pek SLT; Wu X; Leong ML; Tay HM; Hou HW; Ruedl C; Moss SE; Greenwood J; Tavintharan S; Hong W; Wang X
    Diabetes; 2020 Nov; 69(11):2467-2480. PubMed ID: 32887674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Enhanced Leucine-Rich
    Haku S; Wakui H; Azushima K; Haruhara K; Kinguchi S; Ohki K; Uneda K; Kobayashi R; Matsuda M; Yamaji T; Yamada T; Minegishi S; Ishigami T; Yamashita A; Ohashi K; Tamura K
    Biomed Res Int; 2018; 2018():2817045. PubMed ID: 30515388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of human LRG1 recognition by Magacizumab, a humanized monoclonal antibody with therapeutic potential.
    Gutiérrez-Fernández J; Javaid F; De Rossi G; Chudasama V; Greenwood J; Moss SE; Luecke H
    Acta Crystallogr D Struct Biol; 2022 Jun; 78(Pt 6):725-734. PubMed ID: 35647920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-
    Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K
    J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway.
    Dritsoula A; Dowsett L; Pilotti C; O'Connor MN; Moss SE; Greenwood J
    Sci Rep; 2022 Mar; 12(1):4867. PubMed ID: 35318338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling.
    Wang X; Abraham S; McKenzie JAG; Jeffs N; Swire M; Tripathi VB; Luhmann UFO; Lange CAK; Zhai Z; Arthur HM; Bainbridge J; Moss SE; Greenwood J
    Nature; 2013 Jul; 499(7458):306-11. PubMed ID: 23868260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRG1 as a novel therapeutic target in eye disease.
    De Rossi G; Da Vitoria Lobo ME; Greenwood J; Moss SE
    Eye (Lond); 2022 Feb; 36(2):328-340. PubMed ID: 34987199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine Rich α-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis.
    Druhan LJ; Lance A; Li S; Price AE; Emerson JT; Baxter SA; Gerber JM; Avalos BR
    PLoS One; 2017; 12(1):e0170261. PubMed ID: 28081565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRG1 facilitates corneal fibrotic response by inducing neutrophil chemotaxis via Stat3 signaling in alkali-burned mouse corneas.
    Yu B; Yang L; Song S; Li W; Wang H; Cheng J
    Am J Physiol Cell Physiol; 2021 Sep; 321(3):C415-C428. PubMed ID: 34260299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1α activation.
    Zhang J; Zhu L; Fang J; Ge Z; Li X
    J Exp Clin Cancer Res; 2016 Feb; 35():29. PubMed ID: 26856989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of leucine-rich alpha-2-glycoprotein-1 in proliferation, migration, and invasion of tumors.
    Lin M; Liu J; Zhang F; Qi G; Tao S; Fan W; Chen M; Ding K; Zhou F
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):283-291. PubMed ID: 35037101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRG1 mediated by ATF3 promotes growth and angiogenesis of gastric cancer by regulating the SRC/STAT3/VEGFA pathway.
    He L; Feng A; Guo H; Huang H; Deng Q; Zhao E; Yang M
    Gastric Cancer; 2022 May; 25(3):527-541. PubMed ID: 35094168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of transforming growth factor-β-induced kidney fibrosis by leucine-rich ⍺-2 glycoprotein-1.
    Hong Q; Cai H; Zhang L; Li Z; Zhong F; Ni Z; Cai G; Chen XM; He JC; Lee K
    Kidney Int; 2022 Feb; 101(2):299-314. PubMed ID: 34774561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-α-induced LRG1 promotes angiogenesis and mesenchymal stem cell migration in the subchondral bone during osteoarthritis.
    Wang Y; Xu J; Zhang X; Wang C; Huang Y; Dai K; Zhang X
    Cell Death Dis; 2017 Mar; 8(3):e2715. PubMed ID: 28358372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure.
    Song W; Wang X
    Biophys Rev; 2015 Mar; 7(1):91-104. PubMed ID: 28509980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of LRG1 and the functional significance of LRG1 glycan for LPHN2 activation.
    Yang J; Yin GN; Kim DK; Han AR; Lee DS; Min KW; Fu Y; Yun J; Suh JK; Ryu JK; Kim HM
    Exp Mol Med; 2023 May; 55(5):1013-1022. PubMed ID: 37121976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucine rich alpha-2-glycoprotein 1 (Lrg1) silencing protects against sepsis-mediated brain injury by inhibiting transforming growth factor beta1 (TGFβ1)/SMAD signaling pathway.
    Miao Y; Wang M; Cai X; Zhu Q; Mao L
    Bioengineered; 2022 Mar; 13(3):7316-7327. PubMed ID: 35264055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.